OrthoPediatrics Quarterly Cash Flow Statement
NASDAQ: KIDSHealth CareMedical/Dental InstrumentsUSD
21.65-0.11 (-0.51%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OrthoPediatrics free cash flow
In the quarter ended Jun 30, 2026, OrthoPediatrics generated $928,000 of operating cash flow and spent $4.0 million on capital expenditures. That left free cash flow of -$3.1 million, a free-cash-flow margin of -4.4% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
OrthoPediatrics cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -7.16M | -10.69M | -10.10M | -11.77M | -7.11M | -10.66M | -16.07M | -7.92M | -6.03M | -7.80M | -6.69M | -4.59M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | -124.76% |
| Depreciation & Amortization | 5.71M | 5.72M | 5.60M | 5.30M | 5.17M | 5.05M | 3.99M | 5.28M | 4.78M | 5.03M | 5.19M | 4.27M |
| Stock-Based Compensation | 4.19M | 3.98M | 4.42M | 4.25M | 5.25M | 3.86M | 3.89M | 3.92M | 2.94M | 2.80M | 2.75M | 2.36M |
| Change in Working Capital | 6.21M | -3.21M | 10.25M | -5.72M | -3.42M | 254.00K | -753.00K | -12.03M | 357.00K | -6.07M | -10.23M | -6.88M |
| Operating Cash Flow | 928.00K | -3.29M | 10.35M | -581.00K | -10.46M | -4.16M | -3.99M | -10.28M | -6.09M | -6.69M | -7.54M | -8.67M |
| Capital Expenditures | -4.04M | -1.76M | -599.00K | -2.84M | -3.44M | -4.23M | 262.00K | -1.38M | -6.68M | -6.46M | -3.84M | -2.48M |
| Investing Cash Flow | 5.00M | -3.79M | -7.26M | -26.84M | -3.54M | -5.99M | -2.41M | -26.77M | 19.70M | -3.68M | 17.92M | 9.67M |
| Debt Issued | — | — | 0 | 0 | — | — | 0 | 73.53M | — | — | 9.42M | 0 |
| Debt Repaid | — | — | 0 | — | — | — | 0 | — | — | — | 0 | — |
| Financing Cash Flow | -737.00K | -614.00K | -417.00K | -282.00K | 24.80M | -126.00K | -541.00K | 58.52M | -4.27M | -573.00K | 9.39M | -15.00K |
| Net Change in Cash | 4.81M | -7.38M | 2.74M | -27.72M | 11.18M | -10.35M | -7.27M | 22.16M | 7.33M | -9.46M | 20.80M | 923.00K |
| Free Cash Flow | -3.12M | -5.05M | 9.75M | -3.42M | -13.91M | -8.38M | -3.73M | -11.66M | -12.78M | -13.15M | -11.38M | -11.15M |
This table shows 12 quarterly periods of OrthoPediatrics's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KIDS's reporting calendar. What is a cash flow statement?